SIC 8742 – Management Consulting Services
| Valuation | |
|---|---|
| Market Cap ($M) | 15,662.26 |
| Enterprise Value ($M) | 18,582.44 |
| Book Value ($M) | 1,209.92 |
| Book Value / Share | 9.55 |
| Price / Book | 12.94 |
| NCAV ($M) | -2,764.68 |
| NCAV / Share | -21.83 |
| Price / NCAV | -5.67 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.18 |
| Return on Assets (ROA) | 0.13 |
| Return on Equity (ROE) | 0.83 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.57 |
| Current Ratio | 1.57 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 2,846.39 |
| Assets | 6,820.99 |
| Liabilities | 5,611.07 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Price T Rowe Associates Inc /md/ | 5.70 | -18.69 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 209,086 | 861,629 | 24.27 | |
| 253,571 | 971,177 | 26.11 | |
| 453,633 | 1,740,222 | 26.07 | |
| 210,929 | 1,010,428 | 20.88 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| EVH – Evolent Health, Inc. | FC – Franklin Covey Co. |
Financial data and stock pages provided by
Fintel.io